|
325660101
|
ADAKVEO C/S.SOL.IN 10MG/ML 1 VIAL x10 ml
|
|
1.042,35 |
1.159,31 |
1.290,32 |
Novartis Europharm Ltd
|
|
290970301
|
AFINITOR TAB 2,5MG/TAB BTx30 σε BLISTERS (ALU/PA/ALU/PVC) (ALU/PA/ALU/PVC)
|
|
1.078,18 |
1.199,16 |
1.334,67 |
Novartis Europharm Ltd
|
|
290970201
|
AFINITOR TABLET 10MG/TAB BTx30 σε BLISTERS (ALU/PA/ALU/PVC) (ALU/PA/ALU/PVC)
|
|
1.546,47 |
1.720,00 |
1.891,57 |
Novartis Europharm Ltd
|
|
290970101
|
AFINITOR TABLET 5MG/TAB BTx30 σε BLISTERS (ALU/PA/ALU/PVC) (ALU/PA/ALU/PVC)
|
|
1.091,61 |
1.214,09 |
1.351,28 |
Novartis Europharm Ltd
|
|
319540201
|
AIMOVIG INJ.SOL 140MG/ML BTx1 PF. PENx1 ML
|
|
262,71 |
292,19 |
346,89 |
Novartis Europharm Ltd
|
|
319540101
|
AIMOVIG INJ.SOL 70MG/ML BTx1 PF. PENx1 ML
|
|
263,84 |
293,45 |
348,38 |
Novartis Europharm Ltd
|
|
294030103
|
ARZERRA C/S.SOL.IN 20MG/ML BTx1 VIALx 50ML
|
|
1.776,21 |
1.975,51 |
2.304,88 |
Novartis Europharm Ltd
|
|
294030101
|
ARZERRA C/S.SOL.IN 20MG/ML BTx3 VIALSx 5ML
|
|
558,21 |
620,86 |
750,68 |
Novartis Europharm Ltd
|
|
324610202
|
ATECTURA BREEZHALER INHPD.CAP (125+127.5)MCG/DOSE [(150+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
18,04 |
20,74 |
28,58 |
Novartis Europharm Ltd
|
|
324610302
|
ATECTURA BREEZHALER INHPD.CAP (125+260)MCG/DOSE [(150+320) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
19,62 |
22,56 |
31,09 |
Novartis Europharm Ltd
|
|
324610102
|
ATECTURA BREEZHALER INHPD.CAP (125+62.5)MCG/DOSE [(150+80) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
18,00 |
20,69 |
28,51 |
Novartis Europharm Ltd
|
|
279190101
|
ATRIANCE SOL.INF 5MG/ML BTx6 VIALS x50 ML
|
|
1.361,23 |
1.513,96 |
1.664,97 |
Novartis Europharm Ltd
|
|
286490101
|
AZARGA EY.DRO.SUS (10+5)MG/ML BTx 1φιαλίδιο (LDPE) x 5ML (LDPE) x 5ML
|
|
6,69 |
7,69 |
10,60 |
Novartis Europharm Ltd
|
|
248820101
|
AZOPT EY.DRO.SUS 10MG/ML FL X5ML
|
|
3,16 |
3,63 |
5,00 |
Novartis Europharm Ltd
|
|
324600202
|
BEMRIST BREEZHALER INHPD.CAP (125+127.5)MCG/DOSE [(150+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
18,04 |
20,74 |
28,58 |
Novartis Europharm Ltd
|
|
324600302
|
BEMRIST BREEZHALER INHPD.CAP (125+260)MCG/DOSE [(150+320) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
19,62 |
22,56 |
31,09 |
Novartis Europharm Ltd
|
|
324600102
|
BEMRIST BREEZHALER INHPD.CAP (125+62.5)MCG/DOSE [(150+80) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
18,00 |
20,69 |
28,51 |
Novartis Europharm Ltd
|
|
323510101
|
BEOVU INJ.SOL 120MG/ML BTx1 PF.SYRx0.165 ML
|
|
473,62 |
526,76 |
603,03 |
Novartis Europharm Ltd
|
|
276380303
|
COPALIA F.C.TAB (10+160)MG/TAB BTx 28 (σε ΒLISTERS PVC/PVDC) PVC/PVDC)
|
|
6,60 |
7,58 |
10,44 |
Novartis Europharm Ltd
|
|
276380203
|
COPALIA F.C.TAB (5+160)MG/TAB BTx 28 (σε ΒLISTERS PVC/PVDC) PVC/PVDC)
|
|
5,99 |
6,88 |
9,48 |
Novartis Europharm Ltd
|
|
291930202
|
COPALIA HCT F.C.TAB (10+160+12,5)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
8,41 |
9,67 |
13,32 |
Novartis Europharm Ltd
|
|
291930402
|
COPALIA HCT F.C.TAB (10+160+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
9,19 |
10,57 |
14,56 |
Novartis Europharm Ltd
|
|
291930502
|
COPALIA HCT F.C.TAB (10+320+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
13,70 |
15,75 |
21,71 |
Novartis Europharm Ltd
|
|
291930102
|
COPALIA HCT F.C.TAB (5+160+12,5)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
7,30 |
8,39 |
11,56 |
Novartis Europharm Ltd
|
|
291930302
|
COPALIA HCT F.C.TAB (5+160+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
8,52 |
9,79 |
13,49 |
Novartis Europharm Ltd
|
|
309960301
|
COSENTYX IN.SO.PF.P 150MG/ML BTx1 Προγεμισμένη συσκευή τύπου πένας x 150mg/ml
|
|
374,47 |
416,48 |
481,20 |
Novartis Europharm Ltd
|
|
309960302
|
COSENTYX IN.SO.PF.P 150MG/ML BTx2 Προγεμισμένες συσκευές τύπου πένας x 150mg/ml
|
|
800,52 |
890,35 |
1.000,40 |
Novartis Europharm Ltd
|
|
309960202
|
COSENTYX INJ.SO.PFS 150MG/ML BTx2 Προγεμισμένες Γυάλινες Σύριγγες x 150mg/ml
|
|
928,99 |
1.033,23 |
1.225,93 |
Novartis Europharm Ltd
|
|
309960403
|
COSENTYX INJ.SOL 300MG/2ML (150MG/ML) 1 PF.PENx2 ML
|
|
748,92 |
832,94 |
935,90 |
Novartis Europharm Ltd
|
|
272470104
|
DUOTRAV EY.DRO.SOL 40μg/ml+5mg/ml BT x 1 BOTTLE (LDPE) x 2,5 ML
|
|
5,11 |
5,87 |
8,09 |
Novartis Europharm Ltd
|
|
272470101
|
DUOTRAV EY.DRO.SOL 40μg/ml+5mg/ml BT x 1 φιάλη x2,5ML
|
|
5,57 |
6,40 |
8,82 |
Novartis Europharm Ltd
|
|
239740101
|
EMADINE EY.DRO.SOL 0,05% FLx5ML
|
|
5,46 |
6,27 |
8,64 |
Novartis Europharm Ltd
|
|
324840102
|
ENERZAIR BREEZHALER INHPD.CAP (114+46+136)MCG/DOSE [(150+50+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
36,15 |
41,55 |
57,26 |
Novartis Europharm Ltd
|
|
324840103
|
ENERZAIR BREEZHALER INHPD.CAP (114+46+136)MCG/DOSE [(150+50+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής+1 αισθητήρας
|
|
36,15 |
41,55 |
57,26 |
Novartis Europharm Ltd
|
|
312910101
|
ENTRESTO F.C.TAB (24+26)MG/TAB BTx28
|
|
44,35 |
50,98 |
64,85 |
Novartis Europharm Ltd
|
|
312910202
|
ENTRESTO F.C.TAB (49+51)MG/TAB BTx56
|
|
88,08 |
101,24 |
124,49 |
Novartis Europharm Ltd
|
|
312910302
|
ENTRESTO F.C.TAB (97+103)MG/TAB BTx56
|
|
87,92 |
101,06 |
124,26 |
Novartis Europharm Ltd
|
|
281610203
|
EUCREAS F.C.TAB (50+1000)MG/TAB BT x 60 σε BLIST (PA/AL/PVC/AL) (PA/AL/PVC/AL)
|
|
15,11 |
17,37 |
23,93 |
Novartis Europharm Ltd
|
|
281610212
|
EUCREAS F.C.TAB (50+1000)MG/TAB BTx 60 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
22,45 |
25,81 |
35,56 |
Novartis Europharm Ltd
|
|
281610103
|
EUCREAS F.C.TAB (50+850)MG/TAB BT x 60 σε BLIST (PA/AL/PVC/AL) (PA/AL/PVC/AL)
|
|
19,78 |
22,73 |
31,32 |
Novartis Europharm Ltd
|
|
281610112
|
EUCREAS F.C.TAB (50+850)MG/TAB BTx 60 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
30,56 |
35,13 |
48,41 |
Novartis Europharm Ltd
|
|
236030201
|
EXELON CAPS 1.5MG/CAP BTx28(BLIST2x14)
|
|
7,34 |
8,43 |
11,62 |
Novartis Europharm Ltd
|
|
236030301
|
EXELON CAPS 3MG/CAP BTx28(BLIST2x14)
|
|
10,56 |
12,13 |
16,72 |
Novartis Europharm Ltd
|
|
236030401
|
EXELON CAPS 4.5MG/CAP BTx28(BLIST2x14)
|
|
12,19 |
14,01 |
19,30 |
Novartis Europharm Ltd
|
|
236030501
|
EXELON CAPS 6MG/CAP BTx28(BLIST2x14)
|
|
12,62 |
14,51 |
19,99 |
Novartis Europharm Ltd
|
|
236030601
|
EXELON ORAL.SOL 2MG/ML FLx120ML
|
|
37,53 |
43,14 |
59,44 |
Novartis Europharm Ltd
|
|
236030602
|
EXELON ORAL.SOL 2MG/ML ΒOTTLEx50 ML+1 δοσομετρική SYR δοσομετρική SYR
|
|
16,08 |
18,48 |
25,46 |
Novartis Europharm Ltd
|
|
236030906
|
EXELON TTS 13,3MG/24h 30 Φακελλίσκοι
|
|
26,47 |
30,43 |
41,93 |
Novartis Europharm Ltd
|
|
236030902
|
EXELON TTS 13,3MG/24h BTx30 SACHETS
|
|
32,91 |
37,83 |
52,13 |
Novartis Europharm Ltd
|
|
236030708
|
EXELON TTS 4,6MG/24h 30 Φακελλίσκοι
|
|
14,46 |
16,63 |
22,92 |
Novartis Europharm Ltd
|
|
236030702
|
EXELON TTS 4,6MG/24h BTx30 SACHETS
|
|
14,61 |
16,79 |
23,14 |
Novartis Europharm Ltd
|
|
236030808
|
EXELON TTS 9,5MG/24h 30 Φακελλίσκοι
|
|
17,36 |
19,95 |
27,50 |
Novartis Europharm Ltd
|
|
236030802
|
EXELON TTS 9,5MG/24h BTx30 SACHETS
|
|
21,57 |
24,80 |
34,17 |
Novartis Europharm Ltd
|
|
276390303
|
EXFORGE F.C.TAB (10+160)MG/TAB BT x 28 σε BLISTERS (PVC/PVDC) (PVC/PVDC)
|
|
6,60 |
7,58 |
10,44 |
Novartis Europharm Ltd
|
|
276390203
|
EXFORGE F.C.TAB (5+160)MG/TAB BT x 28 σε BLISTERS (PVC/PVDC) (PVC/PVDC)
|
|
5,99 |
6,88 |
9,48 |
Novartis Europharm Ltd
|
|
291940202
|
EXFORGE HCT F.C.TAB (10+160+12,5)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
8,41 |
9,67 |
13,32 |
Novartis Europharm Ltd
|
|
291940402
|
EXFORGE HCT F.C.TAB (10+160+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
9,19 |
10,57 |
14,56 |
Novartis Europharm Ltd
|
|
291940502
|
EXFORGE HCT F.C.TAB (10+320+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
13,70 |
15,75 |
21,71 |
Novartis Europharm Ltd
|
|
291940102
|
EXFORGE HCT F.C.TAB (5+160+12,5)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
7,30 |
8,39 |
11,56 |
Novartis Europharm Ltd
|
|
291940302
|
EXFORGE HCT F.C.TAB (5+160+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC PVC/PVDC
|
|
8,52 |
9,79 |
13,49 |
Novartis Europharm Ltd
|
|
274460501
|
EXJADE F.C.TAB 180MG/TAB BT x 30 δισκία σε BLISTERS (PVC/PVDC/ALU)
|
|
198,38 |
220,64 |
261,95 |
Novartis Europharm Ltd
|
|
274460601
|
EXJADE F.C.TAB 360MG/TAB BT x 30 δισκία σε BLISTERS (PVC/PVDC/ALU)
|
|
393,12 |
437,23 |
505,17 |
Novartis Europharm Ltd
|
|
274460401
|
EXJADE F.C.TAB 90MG/TAB BT x 30 δισκία σε BLISTERS (PVC/PVDC/ALU)
|
|
104,21 |
119,79 |
147,30 |
Novartis Europharm Ltd
|
|
284330104
|
EXTAVIA PS.INJ.SOL 250mcg/ML 15VIALS + 15 PF.SYR x 1,2ML SOLV (οι σύριγγες είναι χωρητικότητας των 2,25ml) x 1,2ML SOLV (οι σύριγγες είναι χωρητικότητας των 2,25ml)
|
|
423,30 |
470,81 |
543,97 |
Novartis Europharm Ltd
|
|
337440102
|
FABHALTA CAPS 200MG/CAP BT X 56 ΚΑΨΑΚΙΑ ΣΕ BLISTER (PVC/PE/PVDC/ALU)
|
|
22.756,26 |
25.309,66 |
27.364,80 |
Novartis Europharm Ltd
|
|
280730103
|
GALVUS TABLET 50 MG/TAB BT x 28 σε ΒLISTERS (PA/AL/PVC/AL) (PA/AL/PVC/AL)
|
|
10,12 |
11,64 |
16,04 |
Novartis Europharm Ltd
|
|
298250103
|
GILENYA CAPS 0,5MG/CAP BTx28 σε BLIST (PVC/PVDC/alu) (PVC/PVDC/alu)
|
|
1.328,99 |
1.478,12 |
1.633,40 |
Novartis Europharm Ltd
|
|
298250105
|
GILENYA CAPS 0,5MG/CAP BTx28 σε BLIST 2x14 (PVC/PVDC/alu) (PVC/PVDC/alu)
|
|
856,48 |
952,58 |
1.065,27 |
Novartis Europharm Ltd
|
|
253440302
|
GLIVEC F.C.TAB 100MG/TAB BTX60
|
|
333,36 |
370,77 |
432,32 |
Novartis Europharm Ltd
|
|
253440305
|
GLIVEC F.C.TAB 100MG/TAB BTx60 δισκία σε Κυψέλη (PVDC/ALU)
|
|
215,67 |
239,87 |
284,77 |
Novartis Europharm Ltd
|
|
253440402
|
GLIVEC F.C.TAB 400MG/TAB BTX30
|
|
389,87 |
433,62 |
501,01 |
Novartis Europharm Ltd
|
|
291660401
|
ILARIS IN.SO.PF.P 150MG/ML BT X 1 PF.PEN X 1ML (150MG)
|
|
7.256,31 |
8.070,52 |
8.725,85 |
Novartis Europharm Ltd
|
|
291660301
|
ILARIS INJ.SOL 150MG/ML BTx1VIAL
|
|
8.323,54 |
9.257,50 |
10.009,21 |
Novartis Europharm Ltd
|
|
291660101
|
ILARIS PD.INJ.SOL 150MG BTx1VIAL
|
|
9.297,91 |
10.341,20 |
11.919,27 |
Novartis Europharm Ltd
|
|
303620406
|
JAKAVI TABLET 10MG/TAB BT x 56 δισκία σε BLISTERS (PVC/PE/PVDC/ALU)
|
|
|
|
|
Novartis Europharm Ltd
|
|
303620403
|
JAKAVI TABLET 10MG/TAB BT x56 δισκία σε BLISTERS (PVC/PCTFE)
|
|
2.482,45 |
2.760,99 |
2.992,50 |
Novartis Europharm Ltd
|
|
303620206
|
JAKAVI TABLET 15MG/TAB BT x 56 δισκία σε BLISTERS (PVC/PE/PVDC/ALU)
|
|
|
|
|
Novartis Europharm Ltd
|
|
303620203
|
JAKAVI TABLET 15MG/TAB BT x56 δισκία σε BLISTERS (PVC/PCTFE/Alu) BLISTERS (PVC/PCTFE/Alu)
|
|
2.431,77 |
2.704,62 |
2.938,57 |
Novartis Europharm Ltd
|
|
303620306
|
JAKAVI TABLET 20MG/TAB BT x 56 δισκία σε BLISTERS (PVC/PE/PVDC/ALU)
|
|
|
|
|
Novartis Europharm Ltd
|
|
303620303
|
JAKAVI TABLET 20MG/TAB BT x56 δισκία σε BLISTERS (PVC/PCTFE/Alu) σε BLISTERS (PVC/PCTFE/Alu)
|
|
2.431,77 |
2.704,62 |
2.938,57 |
Novartis Europharm Ltd
|
|
303620106
|
JAKAVI TABLET 5MG/TAB BT x 56 δισκία σε BLISTERS (PVC/PE/PVDC/ALU)
|
|
|
|
|
Novartis Europharm Ltd
|
|
303620103
|
JAKAVI TABLET 5MG/TAB BT x56 δισκία σε BLISTERS (PVC/PCTFE/Alu) BLISTERS (PVC/PCTFE/Alu)
|
|
1.221,19 |
1.358,21 |
1.500,89 |
Novartis Europharm Ltd
|
|
286730103
|
JALRA F.C.TAB 50mg/tab BTx 28 σε BLISTERS (PA/AL/PVC/AL) (PA/AL/PVC/AL)
|
|
10,12 |
11,64 |
16,04 |
Novartis Europharm Ltd
|
|
327040103
|
KESIMPTA INJ.SOL 20MG/0,4 ML (50MG/ML) 1 PF. PEN x 0,4 ML
|
|
947,01 |
1.053,28 |
1.172,30 |
Novartis Europharm Ltd
|
|
317320102
|
KISQALI F.C.TAB 200MG/TAB BTx21 σε BLISTERS (PA/alu/PVC)
|
|
620,97 |
690,64 |
783,32 |
Novartis Europharm Ltd
|
|
317320101
|
KISQALI F.C.TAB 200MG/TAB BTx21 σε BLISTERS (PCTFE/PVC)
|
|
620,97 |
690,64 |
783,32 |
Novartis Europharm Ltd
|
|
317320104
|
KISQALI F.C.TAB 200MG/TAB BTx42 σε BLISTERS (PA/alu/PVC)
|
|
1.205,61 |
1.340,89 |
1.481,75 |
Novartis Europharm Ltd
|
|
317320103
|
KISQALI F.C.TAB 200MG/TAB BTx42 σε BLISTERS (PCTFE/PVC)
|
|
1.205,61 |
1.340,89 |
1.481,75 |
Novartis Europharm Ltd
|
|
317320106
|
KISQALI F.C.TAB 200MG/TAB BTx63 σε BLISTERS (PA/alu/PVC)
|
|
1.650,53 |
1.835,73 |
2.009,11 |
Novartis Europharm Ltd
|
|
317320105
|
KISQALI F.C.TAB 200MG/TAB BTx63 σε BLISTERS (PCTFE/PVC)
|
|
1.818,78 |
2.022,87 |
2.208,57 |
Novartis Europharm Ltd
|
|
319680101
|
KYMRIAH DISP.INF 1,2x106-6,0x108 κύτταρα 1 ή περισσότεροι σάκκοι Έγχυσης (από συμπολυμερές αιθυλενοξοικού βινυλίου)
|
|
220.043,10 |
244.733,45 |
264.605,81 |
Novartis Europharm Ltd
|
|
326140101
|
LEQVIO INJ.SOL 284MG/1.5 ML(189MG/ML) 1 PF.SYR x1.5 ml
|
|
1.881,64 |
2.092,78 |
2.284,89 |
Novartis Europharm Ltd
|
|
326140102
|
LEQVIO INJ.SOL 284MG/1.5 ML(189MG/ML) 1 PF.SYR x1.5 ml με βελόνα ασφαλείας
|
|
1.809,61 |
2.012,66 |
2.197,42 |
Novartis Europharm Ltd
|
|
276920104
|
LUCENTIS INJ.SOL 10MG/ML BT x 1 VIAL + 1 διηθητική βελόνη
|
|
369,91 |
411,42 |
475,36 |
Novartis Europharm Ltd
|
|
276920101
|
LUCENTIS INJ.SOL 10MG/ML BT x 1 VIAL +1 filter needle+1 injection needle + 1 syringe +1 filter needle+1 injection needle + 1 syringe
|
|
534,87 |
594,88 |
681,02 |
Novartis Europharm Ltd
|
|
276920102
|
LUCENTIS INJ.SOL 10MG/ML BTx1PF.SYRx0,165ML
|
|
369,91 |
411,42 |
475,36 |
Novartis Europharm Ltd
|
|
320710101
|
LUXTURNA C.SO.S.INJ 5x1000000000000 VG/ML Θύλακας αλουμινίου BTx1 VIAL (συμπύκνωμα)+2 VIALSx1.7 ML SOLV
|
|
286.951,56 |
319.149,49 |
345.064,43 |
Novartis Europharm Ltd
|
|
323200102
|
MAYZENT F.C.TAB 0.25MG/TAB 120 δισκία σε Blisters PA/alu/PVC/Alu
|
|
936,50 |
1.041,58 |
1.159,28 |
Novartis Europharm Ltd
|
|
323200101
|
MAYZENT F.C.TAB 0.25MG/TAB Συσκευασία τιτλοποίησης: 12 δισκία σε Blisters PA/alu/PVC/Alu
|
|
84,95 |
97,65 |
124,21 |
Novartis Europharm Ltd
|
|
323200301
|
MAYZENT F.C.TAB 1MG/TAB 28 δισκία σε Blisters PA/alu/PVC/Alu
|
|
1.061,61 |
1.180,73 |
1.314,16 |
Novartis Europharm Ltd
|
|
323200201
|
MAYZENT F.C.TAB 2MG/TAB 28 δισκία σε Blisters PA/alu/PVC/Alu
|
|
987,30 |
1.098,08 |
1.222,16 |
Novartis Europharm Ltd
|
|
308500102
|
MEKINIST F.C.TAB 0.5MG/TAB HDPE BOTTLE x 30 TABS
|
|
773,71 |
860,52 |
966,88 |
Novartis Europharm Ltd
|
|
308500302
|
MEKINIST F.C.TAB 2MG/TAB HDPE BOTTLE x 30 TABS
|
|
3.055,76 |
3.398,63 |
3.674,60 |
Novartis Europharm Ltd
|
|
314230101
|
NEPARVIS F.C.TAB (24+26)MG/TAB BTx28 (PVC/PVDC blister)
|
|
44,35 |
50,98 |
64,85 |
Novartis Europharm Ltd
|
|
314230202
|
NEPARVIS F.C.TAB (49+51)MG/TAB BTx56 (PVC/PVDC blister)
|
|
88,08 |
101,24 |
124,49 |
Novartis Europharm Ltd
|
|
314230302
|
NEPARVIS F.C.TAB (97+103)MG/TAB BTx56 (PVC/PVDC blister)
|
|
87,92 |
101,06 |
124,26 |
Novartis Europharm Ltd
|
|
282090101
|
NEVANAC EY.DRO.SUS 1MG/ML BT x 1 BOTTLE (LDPE) x 5 ML x 5 ML
|
|
9,35 |
10,75 |
14,82 |
Novartis Europharm Ltd
|
|
282090201
|
NEVANAC EY.DRO.SUS 3MG/ML BT x 1 BOTTLE (LDPE) x 3 ML x 3 ML
|
|
14,71 |
16,91 |
23,30 |
Novartis Europharm Ltd
|
|
282090202
|
NEVANAC EY.DRO.SUS 3MG/ML BT x 1 LDPE BOTTLE (OVAL) x 3 ML
|
|
14,71 |
16,91 |
23,30 |
Novartis Europharm Ltd
|
|
292680102
|
ONBREZ BREEZHALER INHPD.CAP 150MCG/CAP BTx30 σε BLISTERS (PA/ALU/PVC) + 1 συσκευή εισπνοής (PA/ALU/PVC) + 1 συσκευή εισπνοής
|
|
15,91 |
18,28 |
25,19 |
Novartis Europharm Ltd
|
|
292680202
|
ONBREZ BREEZHALER INHPD.CAP 300MCG/CAP BTx30 σε BLISTERS (PA/ALU/PVC) + 1 συσκευή εισπνοής (PA/ALU/PVC) + 1 συσκευή εισπνοής
|
|
17,34 |
19,93 |
27,46 |
Novartis Europharm Ltd
|
|
252730101
|
OPATANOL EY.DRO.SOL 1MG/ML FLX5ML
|
|
4,05 |
4,68 |
6,70 |
Novartis Europharm Ltd
|
|
325040102
|
PIQRAY F.C.TAB 150MG/TAB 56 δισκία σε blisters (PVC/PCTFE/alu)
|
|
2.337,31 |
2.599,57 |
2.824,43 |
Novartis Europharm Ltd
|
|
325040302
|
PIQRAY F.C.TAB 200MG/TAB 28 δισκία σε blisters (PVC/PCTFE/alu)
|
|
2.337,31 |
2.599,57 |
2.824,43 |
Novartis Europharm Ltd
|
|
325040202
|
PIQRAY F.C.TAB 50MG/TAB + F.C.TAB 200MG/TAB 56 δισκία (28x50MG + 28x200MG) σε blisters (PVC/PCTFE/alu)
|
|
2.337,31 |
2.599,57 |
2.824,43 |
Novartis Europharm Ltd
|
|
293500102
|
REVOLADE F.C.TAB 25MG/TAB BTx28 σε BLIST (PA/ALU/PVC/ALU) (PA/ALU/PVC/ALU)
|
|
592,33 |
658,79 |
747,20 |
Novartis Europharm Ltd
|
|
293500202
|
REVOLADE F.C.TAB 50MG/TAB BTx28 σε BLIST (PA/ALU/PVC/ALU) (PA/ALU/PVC/ALU)
|
|
1.188,42 |
1.321,77 |
1.460,63 |
Novartis Europharm Ltd
|
|
293500501
|
REVOLADE PD.ORA.SUS 25MG/SACHET 30 φακελίσκοι + 1 φιάλη ανάμιξης + 30 σύριγγες μιας χρήσης για χορήγηση από του στόματος + 1 βιδωτό πώμα με δυνατότητα προσαρμογής στη σύριγγα
|
|
724,12 |
805,37 |
904,91 |
Novartis Europharm Ltd
|
|
317460101
|
RYDAPT SOFT.CAPS 25MG/CAP BTx112 καψάκια (4 BLIST x28) καψάκια σε BLISTERS PA/Al/PVC-Al)
|
|
9.445,40 |
10.505,23 |
11.358,25 |
Novartis Europharm Ltd
|
|
331430102
|
SCEMBLIX F.C.TAB 20MG/TAB BTx 60 ΔΙΣΚΙΑ σε BLISTERS (PCTFE/PVC/ALU)
|
|
3.408,07 |
3.790,48 |
4.098,27 |
Novartis Europharm Ltd
|
|
331430202
|
SCEMBLIX F.C.TAB 40MG/TAB BTx 60 ΔΙΣΚΙΑ σε BLISTERS (PCTFE/PVC/ALU)
|
|
3.408,07 |
3.790,48 |
4.098,27 |
Novartis Europharm Ltd
|
|
278170101
|
SEBIVO F.C.TAB 600 MG/TAB BT x 28 σε BLISTERS (PVC/ALU) (PVC/ALU)
|
|
299,21 |
332,79 |
388,03 |
Novartis Europharm Ltd
|
|
303860103
|
SEEBRI BREEZHALER INHPD.CAP 50mcg/CAP ή 44mcg/DOSE BTx30x1 καψάκιο σε BLIST (alu/alu) + 1 συσκευή εισπνοής BLIST (alu/alu) + 1 συσκευή εισπνοής
|
|
15,29 |
17,57 |
24,21 |
Novartis Europharm Ltd
|
|
308830101
|
SIMBRINZA EY.DRO.SUS (10+2)MG/ML 1BTx1 BOTTLE x5ML
|
|
7,22 |
8,30 |
11,44 |
Novartis Europharm Ltd
|
|
238840301
|
SIMULECT PD.I.S.INF 20MG/VIAL BT X 1 VIAL
|
|
714,45 |
794,61 |
897,04 |
Novartis Europharm Ltd
|
|
238840101
|
SIMULECT PS.SOL.INF 20MG/VIAL BTX1VIAL+1AMP SOLV
|
|
714,45 |
794,61 |
897,04 |
Novartis Europharm Ltd
|
|
248200205
|
STARLIX F.C.TAB 120MG/TAB BTX84
|
|
19,28 |
22,17 |
30,55 |
Novartis Europharm Ltd
|
|
248200305
|
STARLIX F.C.TAB 180MG/TAB BTX84
|
|
19,98 |
22,96 |
31,64 |
Novartis Europharm Ltd
|
|
248200105
|
STARLIX F.C.TAB 60MG/TAB BTX84
|
|
18,88 |
21,70 |
29,90 |
Novartis Europharm Ltd
|
|
331010102
|
TABRECTA F.C.TAB 150MG/TAB BTx 120 δισκία σε BLISTERS (PVC/PE/PVDC/ALU)
|
|
6.798,87 |
7.561,75 |
8.175,76 |
Novartis Europharm Ltd
|
|
331010202
|
TABRECTA F.C.TAB 200MG/TAB BTx 120 δισκία σε BLISTERS (PVC/PE/PVDC/ALU)
|
|
6.798,87 |
7.561,75 |
8.175,76 |
Novartis Europharm Ltd
|
|
305900101
|
TAFINLAR CAPS 50MG/CAP BTx28 (HDPE Bottle)
|
|
744,47 |
828,01 |
930,35 |
Novartis Europharm Ltd
|
|
305900201
|
TAFINLAR CAPS 75MG/CAP BTx28 (HDPE Bottle)
|
|
970,58 |
1.079,48 |
1.201,46 |
Novartis Europharm Ltd
|
|
281690202
|
TASIGNA CAPS 150MG/CAP BTx112 σε BLIST (PVC/PVDC/AL) (PVC/PVDC/AL)
|
|
1.595,44 |
1.774,47 |
1.942,07 |
Novartis Europharm Ltd
|
|
281690106
|
TASIGNA CAPS 200MG/CAP BLISTx112 (PVC/PVDC/AL) σε χάρτινο κουτί (PVC/PVDC/AL) σε χάρτινο κουτί
|
|
2.127,23 |
2.365,93 |
2.576,85 |
Novartis Europharm Ltd
|
|
281690103
|
TASIGNA CAPS 200MG/CAP BT x 112 σε BLIST (PVC/PVDC/AL) (PVC/PVDC/AL)
|
|
2.446,60 |
2.721,12 |
2.956,50 |
Novartis Europharm Ltd
|
|
303870103
|
TOVANOR BREEZHALER INHPD.CAP 50mcg/CAP ή 44mcg/DOSE BTx30x1 καψάκιο σε BLIST (alu/alu) + 1 συσκευή εισπνοής BLIST (alu/alu) + 1 συσκευή εισπνοής
|
|
15,29 |
17,57 |
24,21 |
Novartis Europharm Ltd
|
|
251150103
|
TRAVATAN EY.DRO.SOL 40MC/ML BTx1 BOTTLE (LDPE) x 2,5ML
|
|
3,69 |
4,24 |
5,84 |
Novartis Europharm Ltd
|
|
251150101
|
TRAVATAN EY.DRO.SOL 40MC/ML FLX2,5ML
|
|
5,21 |
5,99 |
8,26 |
Novartis Europharm Ltd
|
|
283710104
|
TYVERB F.C.TAB 250MG/TAB BOTTLE (HDPE)x70
|
|
732,53 |
814,73 |
915,43 |
Novartis Europharm Ltd
|
|
306180103
|
ULTIBRO BREEZHALER INHPD.CAP (85+43)MCG/DOSE[(110+50)MCG/CAP] BTx30 (PA/Alu/PVC-Alu) blisters x1 CAP + 1 συσκευή εισπνοής (PA/Alu/PVC-Alu) blisters x1 CAP + 1 συσκευή εισπνοής
|
|
24,96 |
28,69 |
39,54 |
Novartis Europharm Ltd
|
|
295000102
|
VOTRIENT F.C.TAB 200MG/TAB 1 BOTTLE (HDPE) x 90
|
|
1.642,68 |
1.826,99 |
1.999,55 |
Novartis Europharm Ltd
|
|
295000202
|
VOTRIENT F.C.TAB 400MG/TAB 1 BOTTLE (HDPE) x 60
|
|
1.944,63 |
2.162,83 |
2.361,37 |
Novartis Europharm Ltd
|
|
300200402
|
VOTUBIA DISP.TAB 2MG/TAB BTx30 σε κυψέλη (alu/PA/alu/PVC)
|
|
555,61 |
617,95 |
700,88 |
Novartis Europharm Ltd
|
|
300200501
|
VOTUBIA DISP.TAB 3MG/TAB BTx30 σε κυψέλη (alu/PA/alu/PVC)
|
|
998,48 |
1.110,51 |
1.236,00 |
Novartis Europharm Ltd
|
|
300200601
|
VOTUBIA DISP.TAB 5MG/TAB BTx30 σε κυψέλη (alu/PA/alu/PVC)
|
|
1.389,00 |
1.544,85 |
1.698,95 |
Novartis Europharm Ltd
|
|
300200301
|
VOTUBIA TABLET 10MG/TAB BTx30 σε BLISTERS (alu/PA/alu/PVC)
|
|
1.939,50 |
2.157,13 |
2.355,15 |
Novartis Europharm Ltd
|
|
300200102
|
VOTUBIA TABLET 2,5MG/TAB BTx30 σε BLISTERS (alu/PA/alu/PVC)
|
|
694,50 |
772,42 |
871,99 |
Novartis Europharm Ltd
|
|
300200201
|
VOTUBIA TABLET 5MG/TAB BTx30 σε BLISTERS (alu/PA/alu/PVC)
|
|
1.347,80 |
1.499,03 |
1.656,50 |
Novartis Europharm Ltd
|
|
249920408
|
XOLAIR INJ.SOL 150MG/1,0ML PF.SYR BT X 1 PF. PEN (1ML)
|
|
200,27 |
222,74 |
264,44 |
Novartis Europharm Ltd
|
|
249920405
|
XOLAIR INJ.SOL 150MG/1,0ML PF.SYR BT X 1 PF. SYR (1ML) + 1 NEEDLE (27 GAUGE)
|
|
200,27 |
222,74 |
264,44 |
Novartis Europharm Ltd
|
|
249920401
|
XOLAIR INJ.SOL 150MG/1,0ML PF.SYR BTx1 PF. SYR x1,0ML
|
|
200,27 |
222,74 |
264,44 |
Novartis Europharm Ltd
|
|
249920504
|
XOLAIR INJ.SOL 300MG/2ML BT X 1 PF. PEN (2.0ML)
|
|
399,48 |
444,31 |
513,36 |
Novartis Europharm Ltd
|
|
249920307
|
XOLAIR INJ.SOL 75MG/0,5ML PF.SYR BT X 1 PF. PEN (0,5ML)
|
|
84,04 |
96,60 |
122,88 |
Novartis Europharm Ltd
|
|
249920304
|
XOLAIR INJ.SOL 75MG/0,5ML PF.SYR BT X 1 PF. SYR (0,5ML) + 1 NEEDLE (27 GAUGE)
|
|
84,04 |
96,60 |
122,88 |
Novartis Europharm Ltd
|
|
249920301
|
XOLAIR INJ.SOL 75MG/0,5ML PF.SYR BTx1 PF. SYR x0,5ML
|
|
89,57 |
102,96 |
126,60 |
Novartis Europharm Ltd
|
|
306190103
|
XOTERNA BREEZHALER INHPD.CAP (85+43)MCG/DOSE [110+50)MCG/CAP] BTx30 (PA/Alu/PVC-Alu) blisters x1 CAP + 1 συσκευή εισπνοής (PA/Alu/PVC-Alu) blisters x1 CAP + 1 συσκευή εισπνοής
|
|
24,96 |
28,69 |
39,54 |
Novartis Europharm Ltd
|
|
324850102
|
ZIMBUS BREEZHALER INHPD.CAP (114+46+136)MCG/DOSE [(150+50+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
36,15 |
41,55 |
57,26 |
Novartis Europharm Ltd
|
|
324850103
|
ZIMBUS BREEZHALER INHPD.CAP (114+46+136)MCG/DOSE [(150+50+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής+1 αισθητήρας
|
|
36,15 |
41,55 |
57,26 |
Novartis Europharm Ltd
|
|
325190127
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 10 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190130
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 11 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190133
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 12 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190136
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 13 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190103
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 2 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190106
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 3 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190109
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 4 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190112
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 5 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190115
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 6 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190118
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 7 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190121
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 8 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190124
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 9 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190125
|
ZOLGENSMA SOL.INF 2x1013vg/ml 10 VIALS x8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190128
|
ZOLGENSMA SOL.INF 2x1013vg/ml 11 VIALS x8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190131
|
ZOLGENSMA SOL.INF 2x1013vg/ml 12 VIALS x8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190134
|
ZOLGENSMA SOL.INF 2x1013vg/ml 13 VIALS x8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190137
|
ZOLGENSMA SOL.INF 2x1013vg/ml 14 VIALS x8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190102
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 1 VIAL x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190129
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 10 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190132
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 11 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190135
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 12 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190105
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 2 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190108
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 3 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190111
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 4 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190114
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 5 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190117
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 6 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190120
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 7 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190123
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 8 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190126
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 9 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190101
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190104
|
ZOLGENSMA SOL.INF 2x1013vg/ml 3 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190107
|
ZOLGENSMA SOL.INF 2x1013vg/ml 4 VIALS x8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190110
|
ZOLGENSMA SOL.INF 2x1013vg/ml 5 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190113
|
ZOLGENSMA SOL.INF 2x1013vg/ml 6 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190116
|
ZOLGENSMA SOL.INF 2x1013vg/ml 7 VIALS x8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190119
|
ZOLGENSMA SOL.INF 2x1013vg/ml 8 VIALS x8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
325190122
|
ZOLGENSMA SOL.INF 2x1013vg/ml 9 VIALS x 8.3 ml
|
|
1.427.739,31 |
1.587.941,48 |
1.716.882,33 |
Novartis Europharm Ltd
|
|
286740212
|
ZOMARIST F.C.TAB (50+1000)mg/tab BTx 60 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
22,45 |
25,81 |
35,56 |
Novartis Europharm Ltd
|
|
286740203
|
ZOMARIST F.C.TAB (50+1000)mg/tab BTx 60 σε BLISTERS (PA/AL/PVC/AL) (PA/AL/PVC/AL)
|
|
15,11 |
17,37 |
23,93 |
Novartis Europharm Ltd
|
|
286740112
|
ZOMARIST F.C.TAB (50+850)mg/tab BTx 60 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
30,56 |
35,13 |
48,41 |
Novartis Europharm Ltd
|
|
286740103
|
ZOMARIST F.C.TAB (50+850)mg/tab BTx 60 σε BLISTERS (PA/AL/PVC/AL) (PA/AL/PVC/AL)
|
|
19,78 |
22,73 |
31,32 |
Novartis Europharm Ltd
|
|
312130105
|
ZYKADIA CAPS 150MG/CAP BT X 150 (3 X 50) ΣΕ PVC/PE/PVDC/ALU BLISTER
|
|
3.717,84 |
4.135,01 |
4.470,77 |
Novartis Europharm Ltd
|
|
312130101
|
ZYKADIA CAPS 150MG/CAP BTx150 (3x50) σε PVC/PCTFE/Alu blister (πολυσυσκευασία)
|
|
3.717,84 |
4.135,01 |
4.470,77 |
Novartis Europharm Ltd
|
